title: Expression and functional studies of ubiquitin C-terminal hydrolase L1 regulated genes.
abstract: Deubiquitinating enzymes (DUBs) have been increasingly implicated in regulation of cellular processes, but a functional role for Ubiquitin C-terminal Hydrolases (UCHs), which has been largely relegated to processing of small ubiquitinated peptides, remains unexplored. One member of the UCH family, UCH L1, is expressed in a number of malignancies suggesting that this DUB might be involved in oncogenic processes, and increased expression and activity of UCH L1 have been detected in EBV-immortalized cell lines. Here we present an analysis of genes regulated by UCH L1 shown by microarray profiles obtained from cells in which expression of the gene was inhibited by RNAi. Microarray data were verified with subsequent real-time PCR analysis. We found that inhibition of UCH L1 activates genes that control apoptosis, cell cycle arrest and at the same time suppresses expression of genes involved in proliferation and migration pathways. These findings are complemented by biological assays for apoptosis, cell cycle progression and migration that support the data obtained from microarray analysis, and suggest that the multi-functional molecule UCH L1 plays a role in regulating principal pathways involved in oncogenesis.
authors.affiliation: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
authors.forename: Anjali
authors.initials: A
authors.lastname: Bheda
authors.forename: Julia
authors.initials: J
authors.lastname: Shackelford
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Pagano
mesh_terms: D017209:Apoptosis; D001483:Base Sequence; D002453:Cell Cycle; D002460:Cell Line; D002465:Cell Movement; D049109:Cell Proliferation; D017931:DNA Primers; D005786:Gene Expression Regulation; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D043222:Ubiquitin Thiolesterase / Q000502:physiology*
chemical_list: D017931:DNA Primers; D043222:Ubiquitin Thiolesterase
references.citation: Lung Cancer. 2003 Oct;42(1):9-21
references.pmid: 14512183
references.citation: Proc Natl Acad Sci U S A. 1982 Nov;79(21):6651-5
references.pmid: 6292911
references.citation: Anticancer Res. 2008 Sep-Oct;28(5A):2697-700
references.pmid: 19035297
references.citation: Clin Cancer Res. 2007 Jan 1;13(1):27-37
references.pmid: 17200335
references.citation: Mod Pathol. 2003 Oct;16(10):963-9
references.pmid: 14559978
references.citation: Jpn J Clin Oncol. 2001 Nov;31(11):532-5
references.pmid: 11773260
references.citation: J Cell Mol Med. 2009 Aug;13(8B):1666-1678
references.pmid: 20187292
references.citation: Neurochem Int. 2007 Jul-Sep;51(2-4):105-11
references.pmid: 17586089
references.citation: Brain Res Mol Brain Res. 2004 Jul 5;126(1):88-97
references.pmid: 15207921
references.citation: PLoS One. 2009 Jun 18;4(6):e5955
references.pmid: 19536331
references.citation: J Cell Biochem. 2007 Dec 15;102(6):1400-4
references.pmid: 17979151
references.citation: Int J Cancer. 2008 Jul 1;123(1):32-40
references.pmid: 18398830
references.citation: Hum Mol Genet. 2003 Aug 15;12(16):1945-58
references.pmid: 12913066
references.citation: Semin Cancer Biol. 2002 Jun;12(3):187-95
references.pmid: 12083849
references.citation: Anticancer Res. 2004 Nov-Dec;24(6):3731-4
references.pmid: 15736404
references.citation: Hepatogastroenterology. 2003 Sep-Oct;50(53):1278-80
references.pmid: 14571718
references.citation: Clin Cancer Res. 2006 Mar 15;12(6):1820-7
references.pmid: 16551867
references.citation: Neurosci Lett. 2006 Oct 23;407(2):124-6
references.pmid: 16978776
references.citation: Cell Cycle. 2004 Mar;3(3):343-8
references.pmid: 14726710
references.citation: Oncogene. 1999 May 13;18(19):2988-96
references.pmid: 10378694
references.citation: Oncogene. 2002 May 2;21(19):3003-10
references.pmid: 12082530
references.citation: Science. 1989 Nov 3;246(4930):670-3
references.pmid: 2530630
references.citation: Cancer Sci. 2006 Jun;97(6):523-9
references.pmid: 16734731
references.citation: Eur J Cancer. 2004 Mar;40(4):614-8
references.pmid: 14962731
references.citation: Enzyme Protein. 1996;49(5-6):262-72
references.pmid: 9252784
references.citation: J Proteome Res. 2009 Aug;8(8):3977-86
references.pmid: 19545154
references.citation: Mol Carcinog. 2006 Apr;45(4):260-9
references.pmid: 16402389
references.citation: Oncogene. 2009 Jan 8;28(1):117-27
references.pmid: 18820707
references.citation: Mol Cell Biochem. 2008 Nov;318(1-2):109-15
references.pmid: 18622688
references.citation: Cancer Biol Ther. 2002 Jul-Aug;1(4):337-41
references.pmid: 12432242
references.citation: Apoptosis. 2006 Jun;11(6):1049-59
references.pmid: 16544100
references.citation: J Virol. 1999 Jun;73(6):4678-88
references.pmid: 10233927
references.citation: Cell. 2002 Oct 18;111(2):209-18
references.pmid: 12408865
references.citation: Curr Mol Med. 2003 Nov;3(7):659-71
references.pmid: 14601640
references.citation: Drug Resist Updat. 2007 Feb-Apr;10(1-2):13-29
references.pmid: 17303468
references.citation: J Neurochem. 1983 Jun;40(6):1542-7
references.pmid: 6343558
references.citation: Crit Rev Oncog. 2000;11(1):63-76
references.pmid: 10795627
references.citation: Prostate. 2007 Dec 1;67(16):1761-9
references.pmid: 17929277
references.citation: Nature. 2004 Nov 18;432(7015):298-306
references.pmid: 15549091
references.citation: FASEB J. 1997 Dec;11(14):1245-56
references.pmid: 9409543
references.citation: Clin Cancer Res. 2000 Dec;6(12):4764-7
references.pmid: 11156232